GRIFOLS | GRF - Interest Expense On Debt


GRIFOLS reported EUR141.43M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.





Interest Expense On Debt Change Date
Alcon AG USD 52M 2M Mar/2026
Amadeus IT EUR 20.3M 500K Mar/2026
Amarin USD 3K 5K Dec/2024
argenx SE USD 1000K 172K Mar/2026
AstraZeneca USD 484M 181M Dec/2025
Bayer EUR 675M 87M Dec/2025
Demant DKK 398M 37M Dec/2025
Ence Energia y Celulosa EUR 16.2M 7.1M Dec/2025
Essilor EUR 168M 21M Dec/2025
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 79M 6M Mar/2026
Genmab DKK 10M 27M Dec/2025
GlaxoSmithKline GBP 167M 21M Mar/2026
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Inditex EUR 16M 15M Mar/2026
Lakefront Biotherapeutics EUR 1.72M 940K Sep/2025
Merck EUR 104M 17M Mar/2026
Novartis USD 343M 39M Mar/2026
Philips EUR 83M 26M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 178M 203M Mar/2026
Smith & Nephew USD 69M 1000K Dec/2025
UCB EUR 49M 29M Dec/2025
Viscofan EUR 2.65M 291K Mar/2026